Last updated 2026-06-18
- Raised $100M funding round led by Centurium Capital, Jul 2023
- Raised $70M funding round led by Centurium Capital, Dec 2020
- Raised $30M funding round, Nov 2017
Total raised
$204.0M
Last: 2023-07
Stage
Series C
Founded
2009
Headcount
3
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences
About
MitrAssist has developed an approach to treating patients with life-threatening mitral regurgitation (MR) that involves neither repair nor replacement. Instead, the companys proprietary valve implant is placed on top of the natural valve to work in unison with it and to enhance valve functionality. MitrAssists valve-in-valve approach overcomes the various challenges of MR and offers an alternative treatment solution for all MR patients. Made from biomedical and biological materials, MitrAssists valve offers improved biocompatibility and patient recovery time.
Funding history · 5 rounds · $204.0M total
2023-07
2020-12
2017-11
$30.0M
2014-01
2013-07
$1.0M
Q&A
- What is MitrAssist's primary focus?
- MitrAssist is focused on developing a minimally invasive treatment for mitral regurgitation (MR) using a proprietary valve implant that works in unison with the natural valve.
- When was MitrAssist founded?
- MitrAssist was founded in April 2009.
- What is the current status of MitrAssist?
- MitrAssist is currently inactive, having ceased operations in January 2026.
- How much funding has MitrAssist raised in total?
- MitrAssist has raised a total of $204,000,000.
- When was MitrAssist's most recent funding round and who were the lead investors?
- MitrAssist's most recent funding round was in July 2023, raising $100,000,000 with lead investors Centurium Capital and 6 Dimension Capital.
- Which investors participated in MitrAssist's December 2020 funding round?
- In December 2020, Centurium Capital led a $70,000,000 funding round for MitrAssist, with participation from.
- What is MitrAssist's employee count?
- MitrAssist has 1-10 employees.
- What is the product stage of MitrAssist's technology?
- MitrAssist's product is in the clinical trial stage.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
cardiologyhospitalsdoctorsbiomaterialssurgerymedical-devicesvalvesminimally-invasive
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/2989684 |
Identifiers & details
| Founded | 2009-4 |
|---|---|
| Employees (exact) | 3 |
| Status reason | Non Active, Jan 2026 ceased to operate |